Leqembi Iqlik, a subcutaneous formation of lecanemab, is now available as a maintenance dosing regimen for the treatment of early Alzheimer disease.

The most common prodromal symptom of Parkinson disease among community-dwelling older adults was cognitive deficit, followed by subthreshold parkinsonism, urinary dysfunction, and olfactory ...

The prevalence rates of all noncommunicable conditions were higher in people with chronic back pain vs those without chronic back pain.

Researchers found a dose-dependent positive association between ambient TCE concentrations and risk for Parkinson disease.

This case of a 80-year-old woman with chest pain is used to demonstrate the signs and symptoms of sundowning, along with its management.

Researchers examined whether preterm delivery, known to affect future cardiovascular health, was linked to stroke incidence in Black women. This group was specifically investigated due to their higher ...

Melatonin reduces sleep onset latency and improves sleep efficiency and duration in pediatric patients with neurological and psychiatric conditions.

Increased risk for incident clinical heart failure is associated with cognitive impairment, independent of cardiac function and other HF risk factors.

Researchers found 18.5 million incident cases of cancer (excluding nonmelanoma skin cancers) and 10.4 million deaths in 2023.

The VasCog-2-WSO criteria revise the original VasCog criteria for diagnosing VCID, offering additional guidance on neuroimaging and fluid biomarkers.

The FDA has granted Fast Track designation to Bristol Myers Squibb’s anti-MTBR-tau antibody (BMS-986446) for the treatment of early Alzheimer disease.

Pituitary adenoma risk factors included prior hyperparathyroidism, female sex, and non-missense pathogenic variants among patients with MEN1.